Department of Justice

Pharmaceutical Company Biogen to Pay $900M False Claims Act Settlement

September 29, 2022 - Monday, Boston pharmaceutical company Biogen agreed to pay $900 million to settle a case where it was accused of offering illegal programs that induced physicians to prescribe the drugs Avonex, Tysabri, and Tecfidra.   Whistleblower and former Biogen employee Michael Bawduniak filed and litigated the case on behalf of the federal...

Read More


More Articles

Antitrust Lawsuit against Generic Pharmaceutical Companies Is Amended

by Hayden Schmidt

A Pennsylvania Judge barred plaintiffs in an antitrust lawsuit from recouping substantial financial penalties in their case against a group of pharmaceutical companies. Judge Cynthia Rufe will not...

Eli Lilly Sued by Whistleblower for Pharmaceutical Manufacturing Issue

by Hayden Schmidt

A former employee of Eli Lilly is suing the company, claiming she was terminated after exposing issues with pharmaceutical manufacturing practices at one United States operation. Amrit Mula said that...

St. Jude Medical to Pay $27M to Resolve Healthcare Fraud Allegations

by Samantha McGrail

The Justice Department announced that St. Jude Medical agreed to pay $27 million to resolve a healthcare fraud allegation that it violated the False Claims Act and sold defective heart...

Purdue Pharmaceuticals Pleads Guilty in $8.3B Opioid Settlement

by Samantha McGrail

The Department of Justice (DOJ) recently announced an $8.3 billion settlement in which opioid manufacturer, Purdue Pharmaceuticals, agreed to plead guilty to a three-count felony. As part of the...

Gilead to Pay $97M to Resolve Healthcare Fraud Allegations

by Samantha McGrail

The Department of Justice recently announced that Gilead agreed to pay $97 million to resolve healthcare fraud allegations that it violated the False Claims Act and illegally paid kickbacks to a...

Novartis to Pay $642M to Resolve Healthcare Fraud Allegations

by Samantha McGrail

The Justice Department announced that pharmaceutical company Novartis agreed to pay $642 million in two separate settlements to resolve healthcare fraud allegations involving False Claims Act (FCA)...

DOJ Charges Another Generic Drug Company with Price Setting

by Samantha McGrail

Department of Justice (DOJ) recently charged Glenmark Pharmaceuticals Inc. for the it role in antitrust violations from May 2013 to December 2015. The DOJ’s complaint alleged that the...

Teva Walks Away from Negotiations Over Healthcare Fraud Charges

by Samantha McGrail

The Department of Justice will soon decide whether to charge Teva Pharmaceuticals for an alleged healthcare fraud scheme to fix prices of certain generic medicines. But the company isn’t...

6 Pharmacy Owners, Marketers Charged in $14M Healthcare Fraud Case

by Samantha McGrail

The Department of Justice announced that six Dallas, Texas-area pharmacy owners and marketers were charged for their role in a $14 million healthcare fraud scheme involving illegal kickbacks and...

Generic Drug Company Pays $24.1M to Resolve Antitrust Violations

by Samantha McGrail

The Department of Justice announced that Apotex Corp, a generic pharmaceutical company, agreed to pay a $24.1 million criminal penalty for the role it played in antitrust violations from May 2013 to...

Feds Charge Sandoz for Fixing Generic Drug Prices

by Samantha McGrail

The Department of Justice recently announced that it has charged generic pharmaceutical company Sandoz Inc. for fixing generic drug prices, rigging bids, and other antitrust...

Sanofi to Pay $11.85M to Resolve Medicare Fraud Allegations

by Samantha McGrail

The US Justice Department announced that pharmaceutical company Sanofi SA agreed to pay $11.85 million to resolve Medicare fraud accusations involving a recent charity kickback probe.  Sanofi...

Recent Articles